chr1-78893178-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022159.4(ADGRL4):āc.1761G>Cā(p.Leu587Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000689 in 1,596,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.0000055 ( 0 hom. )
Consequence
ADGRL4
NM_022159.4 missense
NM_022159.4 missense
Scores
2
3
13
Clinical Significance
Conservation
PhyloP100: 3.85
Genes affected
ADGRL4 (HGNC:20822): (adhesion G protein-coupled receptor L4) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in adenylate cyclase-activating G protein-coupled receptor signaling pathway. Predicted to be located in cytoplasmic vesicle and plasma membrane. Predicted to be integral component of plasma membrane. Biomarker of glioblastoma and hypertrophic cardiomyopathy. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27778882).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRL4 | NM_022159.4 | c.1761G>C | p.Leu587Phe | missense_variant | 13/15 | ENST00000370742.4 | NP_071442.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRL4 | ENST00000370742.4 | c.1761G>C | p.Leu587Phe | missense_variant | 13/15 | 1 | NM_022159.4 | ENSP00000359778.3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151470Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151470
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1444804Hom.: 0 Cov.: 29 AF XY: 0.0000111 AC XY: 8AN XY: 718826
GnomAD4 exome
AF:
AC:
8
AN:
1444804
Hom.:
Cov.:
29
AF XY:
AC XY:
8
AN XY:
718826
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151470Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73936
GnomAD4 genome
AF:
AC:
3
AN:
151470
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73936
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.1761G>C (p.L587F) alteration is located in exon 13 (coding exon 13) of the ADGRL4 gene. This alteration results from a G to C substitution at nucleotide position 1761, causing the leucine (L) at amino acid position 587 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N
REVEL
Benign
Sift
Benign
T;D
Sift4G
Uncertain
T;T
Polyphen
0.011
.;B
Vest4
0.56
MutPred
0.66
.;Loss of catalytic residue at L587 (P = 0.1256);
MVP
MPC
0.051
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at